Scantox Neuro Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
80
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Scantox Neuro General Information
Description
Operator of a contract research organization intended to provide preclinical and clinical research services. The company offers a sophisticated range of validated transgenic and non-transgenic in vivo and in vitro models for neurodegenerative and rare diseases.
Contact Information
Website
www.scantoxneuro.comCorporate Office
- Parkring 12
- Grambach, 8074
- Austria
Corporate Office
- Parkring 12
- Grambach, 8074
- Austria
Scantox Neuro Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Scantox Neuro Signals
Scantox Neuro Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Scantox Neuro FAQs
-
When was Scantox Neuro founded?
Scantox Neuro was founded in 1999.
-
Where is Scantox Neuro headquartered?
Scantox Neuro is headquartered in Grambach, Austria.
-
What is the size of Scantox Neuro?
Scantox Neuro has 80 total employees.
-
What industry is Scantox Neuro in?
Scantox Neuro’s primary industry is Biotechnology.
-
Is Scantox Neuro a private or public company?
Scantox Neuro is a Private company.
-
What is Scantox Neuro’s current revenue?
The current revenue for Scantox Neuro is
. -
Who are Scantox Neuro’s investors?
JSW-Clinical Investigations and QPS Holdings have invested in Scantox Neuro.
-
When was Scantox Neuro acquired?
Scantox Neuro was acquired on 02-Apr-2024.
-
Who acquired Scantox Neuro?
Scantox Neuro was acquired by Scantox.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »